⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Ginsenosides
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-10-01 — Traditional Chinese Medicine Formulas in Delaying Aging: From Theoretical Foundations to Molecular Mechanisms and Translational Perspectives.: Review situates ginseng-derived formulas within a broader TCM multi-component, multi-pathway anti-aging framework and advocates network pharmacology plus proteomic aging clocks for deconvolving active constituents — contextual synthesis, no new ginsenoside-specific outcome data. [expert-opinion] (novelty: 3)
- 2026-07-22 — Effect of Rg1-based Supplementation on Exercise Training-induced Stem Cell Recruitments and Skeletal Muscle Adaptation in Women Aged > 60: Early human trial in women >60 testing Rg1-based Senactiv® as an adjunct to long-term exercise training, with bone marrow-derived stem cell recruitment and skeletal muscle adaptation as endpoints (framed toward sarcopenia and cognitive decline) — extends the Rg1 + exercise line from acute crossover to a longer training protocol; readouts pending. [human-rct] (novelty: 3)
- 2026-04-30 — Damage-induced muscle regeneration after exercise in humans: Modulatory effects of ginsenoside Rg1.: Narrative review positions ginsenoside Rg1 as the only ginsenoside with human muscle-biopsy support for modulating exercise damage–regeneration — proposing reduced perceived exertion and post-injury senolytic action within a testable mechanistic framework; synthesis of prior human/preclinical data, no new primary readout. [mechanism-plausible] (novelty: 3)
- 2026-04-02 — Ginsenoside Rg1 enhances stem cell abundance in aging human skeletal muscle after resistance exercise.: Small randomized crossover trial in women >60 (10 mg ginsenoside Rg1 pre-resistance exercise) doubled high-mitochondrial mesenchymal stem cells and mitochondrial content in muscle, attenuated progenitor depletion, and restored estradiol while raising progesterone versus exercise alone — first human trial signal, small n and surrogate endpoints. [human-rct] (novelty: 3)
- 2026-04-02 — Ginsenoside Rb1 mitigates senescence-associated hepatic steatosis in mice through enhanced lysine degradation.: Naturally-aged mouse study: ginsenoside Rb1 reduced hepatocellular senescence and age-related hepatic steatosis, inflammation, and fibrosis by activating lysine degradation (TML pathway) and remodeling lipid metabolism — preclinical mechanistic addition, no human data. [animal-model] (novelty: 3)
- 2026-07-05 — Ginsenosides mitigate multi-organ aging: mechanistic insights from a preclinical systematic review and meta-analysis.: Preclinical systematic review/meta-analysis of 45 D-galactose murine studies reports ginsenosides attenuate multi-organ aging via anti-inflammatory, antioxidant, anti-fibrotic, and anti-apoptotic effects on senescence and oxidative-stress markers — synthesis of animal data only, no human outcomes. [animal-model] (novelty: 3)
- 2026-08-17 — Gut microbial load mediates the longevity effect of Korean red ginseng in Drosophila melanogaster.: Drosophila study: Korean red ginseng extended fly lifespan by reducing total gut microbial load (not composition), and the IIS and Sir2 pathway modulation required this microbial-load reduction — mechanistic advance but preclinical only. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Decoding Ginsenosides: The Structural and Therapeutic Core of Ginseng.
07-oct-2026
novelty 2
per-area 2
strengthens
Traditional Chinese Medicine Formulas in Delaying Aging: From Theoretical Foundations to Molecular Mechanisms and Translational Perspectives.
01-oct-2026
novelty 3
per-area 3
strengthens
Traditional Chinese medicine-derived natural products and formulations as pharmacological modulators of ageing-related pathways: mechanisms and therapeutic potential.
01-oct-2026
novelty 2
per-area 2
strengthens
Ginseng-Schisandra ameliorates D-galactose-induced cognitive impairment in mice: Evidence from gut microbiota and metabolomic analyses.
28-sep-2026
novelty 2
per-area 2
strengthens
Targeting cellular senescence with Traditional Chinese Medicine: advances in neurodegenerative disorder treatment.
19-aug-2026
novelty 2
per-area 2
strengthens
Gut microbial load mediates the longevity effect of Korean red ginseng in Drosophila melanogaster.
17-aug-2026
novelty 3
per-area 3
strengthens
Tongxinluo attenuates pulmonary microvascular endothelial cell senescence in COPD by targeting the GADD45B-MAPK axis.
05-aug-2026
novelty 2
per-area 2
strengthens
Integrating exercise and nutrition to combat frailty: a systematic review of multidomain interventions in aging populations.
05-aug-2026
novelty 2
per-area 2
mentions
Research progress of traditional Chinese medicine interventions for aging-related nervous system diseases.
01-aug-2026
novelty 2
per-area 2
mentions
Protective effects of polysaccharides derived from Panax ginseng and Codonopsis pilosula against doxorubicin-induced myocardial senescence.
28-jul-2026
novelty 2
per-area 1
mentions
Effect of Rg1-based Supplementation on Exercise Training-induced Stem Cell Recruitments and Skeletal Muscle Adaptation in Women Aged > 60
22-jul-2026
novelty 3
per-area 3
strengthens
Corrigendum to "Total saponins from Panax japonicus mediate the paracrine interaction between adipocytes and macrophages to promote lipolysis in the adipose tissue during aging via the NLRP3 inflammasome/GDF3/ATGL axis" [Phytomedicine 2025 Jan:136:156304].
18-jul-2026
novelty 1
per-area 1
mentions
Aerobic conditioning and ginsenoside modulation modify molecular resilience in middle-aged rats: Differential effects of individual and combined interventions.
11-jul-2026
novelty 2
per-area 2
strengthens
Ginsenosides mitigate multi-organ aging: mechanistic insights from a preclinical systematic review and meta-analysis.
05-jul-2026
novelty 3
per-area 3
strengthens
Comparative pharmacokinetics of total ginsenosides between young and aging mice.
30-jun-2026
novelty 2
per-area 2
strengthens
The orexinergic crossroads: Bidirectional links between sleep-wake disturbances and the pathogenesis of Alzheimer's disease in the aging brain.
04-jun-2026
novelty 2
per-area 3
strengthens
Damage-induced muscle regeneration after exercise in humans: Modulatory effects of ginsenoside Rg1.
30-apr-2026
novelty 3
per-area 3
strengthens
Ginsenoside Rg1 enhances stem cell abundance in aging human skeletal muscle after resistance exercise.
02-apr-2026
novelty 3
per-area 3
strengthens
Ginsenoside Rb1 mitigates senescence-associated hepatic steatosis in mice through enhanced lysine degradation.
02-apr-2026
novelty 3
per-area 3
strengthens
Korean red ginseng extract ameliorates high-fat diet-induced hyperlipidemia by modulating the gut microbiota-liver metabolic axis.
16-jan-2026
novelty 2
per-area 2
strengthens